Feline sarcoma-related protein expression correlates with malignant aggressiveness and poor prognosis in renal cell carcinoma

Cancer Science

Volumn 104, Issue 6, 2013, Pages 681-686

  Miyata, Yasuyoshi ^a,b   Kanda, Shigeru ^c   Sakai, Hideki ^a   Greer, Peter A ^b  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b QUEEN S UNIVERSITY   (Canada)

^c National Hospital Organization Nagasaki Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE FER;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; CELL NUCLEUS; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL FEATURE; COLONY FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISTANT METASTASIS; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CARCINOMA; KIDNEY TUBULE CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR GROWTH;

BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN-TYROSINE KINASES; TUMOR MARKERS, BIOLOGICAL;

EID: 84878181808     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12140     Document Type: Article

References (30)

1. Greer P. Closing in on the biological functions of FPS/FES and FER. Nat Rev Mol Cell Biol 2002; 3: 278-89.
2. Letwin K, Yee SP, Pawson T. Novel protein-tyrosine kinase cDNAs related to Fps/Fes and Eph coned using anti-phosphotyrosine antibody. Oncogene 1998; 3: 621-7.
3. Allard P, Zoubeidi A, Nguyen LT et al. Links between Fer tyrosine kinase expression levels and prostate cell proliferation. Mol Cell Endocrinol 2000; 159: 63-77.
4. Pasder O, Shpungin S, Salem Y et al. Downregulation of Fer induces PP1 activation and cell-cycle arrest in malignant cells. Oncogene 2006; 25: 4149-206.
5. Zoubeidi A, Rocha J, Zouanat FZ et al. The Fer tyrosine kinase cooperates with interleuikin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth. Mol Cancer Res 2009; 7: 142-55.
6. Rosato R, Veltmaat JM, Groffen J, Heisterkamp N. Involvement of the tyrosine kinease fer in cell adhesion. Mol Cell Biol 1998; 18: 5762-70.
7. Xu G, Craig AWB, Greer P et al. Continuous association of cadherin with β-catenin requires the non-receptor tyrosine-kinase Fer. J Cell Sci 2004; 117: 3207-19.
8. Sangrar W, Gao Y, Scott M, Truesdell P, Greer PA. Fer-mediated cortactin phosphorylation is associated with efficient fibroblast migration and is dependent on reactive oxygen species generation during integrin-mediated cell adhesion. Mol Cell Biol 2007; 27: 6140-52.
9. Varkarakis MJ, Bhanalaph T, Moore RH, Murphy GP. Prognostic criteria of renal cell carcinoma. J Surg Oncol 1974; 6: 97-107.
10. Bleumer I, Oosterwijk E, De Mulder P, Mulders PF. Immunotherapy for renal cell carcinoma. Eur Urol 2003; 44: 65-75.
11. Lam JS, Leppert JT, Figlin RA, Belldegrun AS. Surveillance following radical or partial nephrectomy for renal cell carcinoma. Curr Urol Rep 2005; 6: 7-18.
12. Coppin C, Kollmannsberger C, Le L, Porzsolt F, Wilt TJ. Targeted therapy for advanced renal cell cancer (RCC): a Cochrane systematic review of published randomised trials. BJU Int 2011; 108: 1556-63.
13. Tamaskar I, Pili R. Update on novel agents in renal cell carcinoma. Expert Rev Ant 2009; 9: 1817-27.
14. Kanda S, Miyata Y, Kanetake H, Smithgall TE. Downregulation of the c-Fes protein-tyrosine kinase inhibits the proliferation of human renal carcinoma cells. Int J Oncol 2009; 34: 89-96.
15. Shapovalova Z, Tabunshchyk K, Greer PA. The Fer tyrosine kinase regulates an axon retraction response to Semaphorin 3A in dorsal root ganglion neurons. BMC Dev Biol 2007; 30: 133.
16. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-63.
17. Miyata Y, Koga S, Kanda S, Nishikido M, Hayashi T, Kanetake H. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival. Clin Cancer Res 2003; 9: 1741-9.
18. Ohba K, Miyata Y, Watanabe S et al. Clinical significance and predictive value of prostaglandin E2 receptors (EPR) 1 - 4 in patients with renal cell carcinoma. Anticancer Res 2011; 31: 597-605.
19. Watanabe S, Miyata Y, Kanda S et al. Expression of X-linked inhibitor of apoptosis protein in human prostate cancer specimens with and without neo-adjuvant hormonal therapy. J Cancer Res Clin Oncol 2010; 136: 787-93.
20. Orlovsky K, Theodor L, Malovani H, Chowers Y, Nir U. Gamma interferon down-regulates Fer and induces its association with inactive Stat3 in colon carcinoma cells. Oncogene 2002; 21: 4997-5001.
21. Kowalski JR, Egile C, Gil S, Snapper SB, Li R, Thomas SM. Cortactin regulates cell migration through activation of N-WASP. J Cell Sci 2005; 118: 79-87.
22. Yamada S, Yanamoto S, Kawasaki G, Mizuno A, Nemoto TK. Overexpression of cortactin increases invasion potential in oral squamous cell carcinoma. Pathol Oncol Res 2010; 16: 523-31.
23. Luo ML, Shen XM, Zhang Y et al. Amplification and over expression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promote cell migration and anoikis resistance. Cancer Res 2006; 66: 11690-9.
24. Weaver AM. Cortactin in tumor invasiveness. Cancer Lett 2008; 265: 157-66.
25. Aaltomaa S, Lipponen P, Kärjä V, Lundstedt S, Lappi J, Kosma VM. The expression and prognostic values of α-, β-, γ-catenins in renal cell carcinoma. Anticancer Res 2004; 24: 2407-14.
26. Gervais ML, Henry PC, Saravanan A et al. Nuclear E-cadherin and VHL immunoreactivity are prognostic indicators of clear-cell renal cell carcinoma. Lab Invest 2007; 87: 1252-64.
27. McCafferty DM, Craig AW, Senis YA, Greer PA. Absence of Fer protein-tyrosine kinase exacerbates leukocyte recruitment in response to endotoxin. J Immunol 2002; 168: 4930-5.
28. Qi W, Ebbert KV, Craig AW, Greer PA, McCafferty DM. Absence of Fer protein tyrosine kinase exacerbates endotoxin induced intestinal epithelial barrier dysfunction in vivo. Gut 2005; 54: 1091-7.
29. Craig AW, Zirngibl R, Williams K, Cole LA, Greer PA. Mice devoid of fer protein-tyrosine kinase activity are viable and fertile but display reduced cortactin phosphorylation. Mol Cell Biol 2001; 21: 603-13.
30. Craig AW, Greer PA. Fer kinase is required for sustained p38 kinase activation and maximal chemotaxis of activated mast cells. Mol Cell Biol 2002; 22: 6363-74.